Dr Gloria is a physician currently based at Kenyatta National Hospital, Cancer Treatment Center.
She has interests in management of solid cancers and cancer research.

She holds a Bachelor’s Degree in Medicine and Surgery and a Master’s Degree in Internal medicine from the University of Nairobi and an MSC in Oncology from Queen Mary University of London.

Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, an organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs.

e is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya, Rwanda, Tanzania and Uganda), Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics & therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program, Oncology Pharmacy program and assisted in the development of gynecologic oncology program. He also conducts Oncology and Hematology Clinical Trials in SSA.

He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya. In this role he developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Breast Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers in SSA.

He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force and as a Peer reviewer to ASCO Journals. He is also currently a member of ASCO-ESMO Global Oncology Curriculum committee and a member of ASCO’s board of directors. He has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States’ National Cancer Institute’s Pearline Global Cancer Research Humanitarian Award, 2020; The Children’s Place International ‘s 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He is the current Interim President of the College of Oncology of East, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local, regional and International professional conferences and events including ASCO, AORTIC, KESHO, Africa Cancer ECHO, APCA amongst others.

e did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States.

Mohammed Ezzi is a Lecturer and Consultant Medical Oncologist in the Department of Clinical Medicine and Therapeutics at the University of Nairobi in Nairobi, Kenya. He is the current Chair for the Education & Training Subcommittee at Kenya Society of Hematology and Oncology (KESHO) He is the former Treasurer for KESHO.

He did his Internal Medicine residency at the University of Nairobi and subsequently did a two-year fellowship in Medical Oncology at the same university. He is currently a fellow at the College of the European School of Oncology and pursuing a Certificate in Competence in Breast Cancer by the European School of Oncology.

His academic focus is in medical education and is passionate about teaching across the spectrum of medical learners with an interest in enhancing oncologic knowledge amongst non-oncologist. He has presented at several symposia, workshops and conferences both locally and internationally. He has several publications in peer reviewed international journals. Dr. Mohammed Ezzi is a member of KESHO, ASCO, ESMO, AORTIC and KAP. His key areas of interest include breast cancer, malignant hematology and clinical pharmacology.

Dr. Nanji is a surgeon-scientist with the Department of Surgery at Queen’s University. He has earned a MD, PhD, and designation as a clinical investigator through the Royal College of Physicians and Surgeons. He has dual fellowship accreditation in hepatobiliary and pancreatic surgery as well as multi-visceral organ transplantation. His clinical training and research interests have provided opportunities to work in several institutions including the Universities of British Columbia, Alberta and Toronto as well as Emory University, Kings College Hospital in London, UK and the National Aeronautics and Space Administration (NASA). His current research interests in oncology complement his clinical practice in the surgical treatment of hepatobiliary and pancreatic malignancies. He conducts translational research in the epigenetics of human liver cancer to better risk stratify and treat patients with liver cancer. He also conducts epidemiological and health services research in HPB malignancies through the Cancer Research Institute at Queen’s University. More recently, he is completing a Master’s degree in Global Surgery to advance his clinical and academic interests in global surgical development. Outside of his professional commitments, he enjoys playing guitar, martial arts and spending time outdoors with his wife and 3 children.

Dr. Irene Weru has worked at Kenyatta National Hospital since 2003 and is current head of clinical pharmacy. Dr. Weru holds a master’s degree in Clinical Pharmacy with sub-specialization in oncology pharmacy from the University of Nairobi.

Dr. Weru is a member of various National and international technical working groups including Demand Forecasting and Quantification TWG of the Coalition for Access to NCD Medicines, ChemoSafe Regional TWG, Pharmacy Advisory Council -Global HOPE Pediatric Hematology /Oncology Centers of Excellence and NCI-Kenya Quality Management Expert Working Group.

Dr. Weru is a member of several professional associations including HOPAK, PSK, KESHO and ISOPP. She is the current Secretary to the International Society of Oncology Pharmacy Practitioners (ISOPP).

Besides oncology, Dr. Weru has interest in medicines management and use especially medicine formulary management. She is also an honorary lecturer at University of Nairobi, School of Pharmacy and provides research and clinical practice supervision to undergraduate and postgraduate students.

Gladys is Palliative care Nurse/Counselor, she holds a bachelor of science in palliative care from Makerere university- Uganda and a post graduate diploma in palliative care from Cardiff University- UK. She owns a higher diploma in counseling psychology in medical health from Kenya Institute of psychological Counseling and a certificate in trainer of trainers (TOT) in End-of-life Nursing Continuum, Trained by the ELNC- USA.

Gladys has a vast amount of experience in palliative care and counseling after working in different departments of KNH.

She currently coordinates Palliative Care Services in the busy Pain & Palliative Care Unit, KNH after previously being involved in establishing and coordinating the successful Patient Navigation Program at Cancer Treatment Center -KNH, a program initiated by the American Cancer Society in partnership with KNH and has greatly improved patients experience and quality of life as they undergo cancer treatment.

Gladys is a co-founder and a former National treasurer of The Oncology Nurses chapter-Kenya.